The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis

Rheumatology International

Volumn 35, Issue 12, 2015, Pages 2041-2046

  Pappone, Nicola ^a   Di Minno, Matteo Nicola Dario ^b   Iervolino, Salvatore ^a   Lupoli, Roberta ^b   Mader, Reuven ^c   Zincarelli, Carmela ^a   Peluso, Rosario ^b  

^a Rheumatology and Rehabilitation Research Unit   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Diffuse idiopathic skeletal hyperostosis; Minimal disease activity; Psoriatic arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BATH ANKYLOSING SPONDYLITIS METROLOGY INDEX; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; HYPEROSTOSIS; IDIOPATHIC DISEASE; JOINT FUNCTION; MAJOR CLINICAL STUDY; MALE; MINIMAL DISEASE ACTIVITY; MUSCULOSKELETAL DISEASE ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RESNICK AND NIWAYAMA CRITERIA; SPINE MOBILITY; SPINE RADIOGRAPHY; VISUAL ANALOG SCALE; WAIST CIRCUMFERENCE; AGED; ANKYLOSING HYPEROSTOSIS; ANTAGONISTS AND INHIBITORS; ARTHRITIS, PSORIATIC; COMPLICATION; JOINT CHARACTERISTICS AND FUNCTIONS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINE; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; MALE; MIDDLE AGED; RANGE OF MOTION, ARTICULAR; SPINE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947616312     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3303-4     Document Type: Article

References (20)

1. Mader R, Buskila D, Verlaan JJ, Atzeni F, Olivieri I, Pappone N et al (2013) Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one. Rheumatology (Oxford) 52(2):326–330
2. Mader R, Sarzi-Puttini P, Atzeni F, Olivieri I, Pappone N, Verlaan JJ et al (2009) Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis [review]. Rheumatology (Oxford) 48:1478–1481
3. Russolillo A, Iervolino S, Peluso R, Lupoli R, Di Minno A, Pappone N et al (2013) Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford) 52(1):62–67
4. Olivieri I, D’Angelo S, Palazzi C, Padula A, Mader R, Khan MA (2009) Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis. Curr Rheumatol Rep 11(5):321–328
5. Haddad A, Thavaneswaran A, Toloza S, Chandran V, Gladman DD (2013) Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis. J Rheumatol 40(8):1367–1373
6. Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Tarantino G et al (2012) Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther 14(5):R211
7. Di Minno MN, Iervolino S, Peluso R, Di Scarpa R, Minno G, CaRRDs Study Group (2011) Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol 31(3):705–712
8. Di Minno MN, Tufano A, Guida A, Di Capua M, De Gregorio AM et al (2011) Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res 127(3):193–197
9. Baraliakos X, Listing J, Rudwaleit M, Haibel H, Brandt J, Sieper J et al (2007) Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 66:910–915
10. Zincarelli C, Iervolino S, Di Minno MN, Miniero E, Rengo C, Di Gioia L et al (2012) Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases. Arthritis Care Res (Hoboken) 64(11):1765–1769
11. Pappone N, Lubrano E, Esposito-del Puente A, D’Angelo S, Di Girolamo C, Del Puente A (2005) Prevalence of diffuse idiopathic skeletal hyperostosis in a female Italian population. Clin Exp Rheumatol 23:123–124
12. Olivieri I, Vitali C, Gemignani G, Pasero G (1989) Concomitant ankylosing spondylitis and DISH. J Rheumatol 16:1170–1172
13. Rillo OL, Scheines EJ, Moreno C, Barreira JC, Porrini AA, Maldonado Cocco JA (1989) Coexistence of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis. Clin Rheumatol 8:499–503
14. Di Minno MN, Iervolino S, Lupoli R, Russolillo A, Coppola A, Peluso R et al (2012) Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost 38(5):497–505
15. Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R et al (2013) Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res (Hoboken) 65(1):141–147
16. Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, CaRRDs Study Group (2014) Weight loss and achievement of minimal disease activity in patientswith psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis 73(6):1157–1162
17. Peluso R, Cafaro G, Di Minno A, Iervolino S, Ambrosino P, Lupoli G et al (2013) Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies. Clin Rheumatol 32:743–753
18. Iervolino S, Di Minno MN, Peluso R, Lofrano M, Russolillo A, Di Minno G et al (2012) Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers. J Rheumatol 39:568–573
19. di Girolamo C, Pappone N, Rengo C, Miniero E, Crisci C, Olivieri I (2001) Intervertebral disc lesions in diffuse idiopathic skeletal hyperostosis (DISH). Clin Exp Rheumatol. 19(3):310–312
20. Olivieri I, D’Angelo S, Palazzi C, Padula A (2013) Spondyloarthritis and diffuse idiopathic skeletal hyperostosis: two different diseases that continue to intersect. J Rheumatol 40:1251–1253